Bastide Le Confort Médical (BLC) Q1 24/25 TU earnings summary

Executive summary

• Achieved 9.0% organic revenue growth in Q1 2024-2025, reaching €133.8 million, with strong momentum in home healthcare services and a rebound in homecare.

• Finalized disposal of Swiss commercial business; 2024-2025 revenue and margin targets reaffirmed.

Financial highlights

• Q1 2024-2025 revenue: €133.8 million, up 9.1% year-over-year (restated 2023-2024: €122.7 million).

• Home healthcare services revenue up 10.9%, now 63.2% of total revenue.

• Homecare revenue up 6.0% to €49.2 million, driven by rental activities.

• International business contributed 16% of total revenue.

Outlook and guidance

• Revenue target for 2024-2025 confirmed at over €560 million.

• Recurring operating margin target of at least 8.7% for 2024-2025, supported by cost control and higher value-added business mix.

• Focus on debt reduction and improved leverage through profitability, working capital management, and asset disposals.